Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Ciurea

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
RMD Open|June 5, 2023
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registryAdrian Ciurea, Andrea Götschi, Seraphina Kissling, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2016
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial SpondyloarthritisMichael J Nissen, Adrian Ciurea, Jürg Bernhard, et al.
The Journal of Rheumatology|January 17, 2018
Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort StudyPascal Zufferey, Almut Scherer, Michael J Nissen, et al.
Arthritis Research & Therapy|June 10, 2021
Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitorsMichael J Nissen, Burkhard Möller, Adrian Ciurea, et al.
Journal of Ultrasonography|April 22, 2022
Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohortRaphael Micheroli, Almut Scherer, Kristina Bürki, et al.
Rheumatology (Oxford, England)|September 7, 2023
Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint countsBurkhard Möller, Godehard A Scholz, Jennifer Amsler, et al.
RMD Open|October 21, 2022
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Frontiers in Cardiovascular Medicine|June 4, 2024
Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritisDenis Mongin, Sabrina Pagano, Celine Lamacchia, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohortRaphael Micheroli, Christoph Tellenbach, Almut Scherer, et al.
RMD Open|February 23, 2024
Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potentialVeronica Martini, Ylenia Silvestri, Adrian Ciurea, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
RMD Open|June 5, 2023
Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registryAdrian Ciurea, Andrea Götschi, Seraphina Kissling, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2016
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial SpondyloarthritisMichael J Nissen, Adrian Ciurea, Jürg Bernhard, et al.
The Journal of Rheumatology|January 17, 2018
Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort StudyPascal Zufferey, Almut Scherer, Michael J Nissen, et al.
Arthritis Research & Therapy|June 10, 2021
Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitorsMichael J Nissen, Burkhard Möller, Adrian Ciurea, et al.
Journal of Ultrasonography|April 22, 2022
Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohortRaphael Micheroli, Almut Scherer, Kristina Bürki, et al.
Rheumatology (Oxford, England)|September 7, 2023
Biologic disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint countsBurkhard Möller, Godehard A Scholz, Jennifer Amsler, et al.
RMD Open|October 21, 2022
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Frontiers in Cardiovascular Medicine|June 4, 2024
Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritisDenis Mongin, Sabrina Pagano, Celine Lamacchia, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohortRaphael Micheroli, Christoph Tellenbach, Almut Scherer, et al.
RMD Open|February 23, 2024
Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potentialVeronica Martini, Ylenia Silvestri, Adrian Ciurea, et al.
Pageof 13